Combination Creates the Leading Healthcare REIT with Pro Forma Equity
Value of Approximately $17 Billion and Enterprise Value of Approximately
$23 Billion
Transaction Expected to be Immediately Accretive to FFO and FAD
CHICAGO & NEWPORT BEACH, Calif., Feb 28, 2011 (BUSINESS WIRE) --
Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") and Nationwide
Health Properties, Inc. (NYSE:NHP) ("NHP") today announced that the
Boards of Directors of both companies have unanimously approved a
definitive agreement under which Ventas will acquire all of the
outstanding shares of NHP in a stock-for-stock transaction valued at
$7.4 billion, creating one of the largest publicly traded REITs and the
leading healthcare REIT by equity value.
Under the terms of the agreement, NHP shareholders will receive a fixed
exchange ratio of 0.7866 Ventas shares for each share of NHP common
stock they own. Based on the closing stock price for Ventas on Friday,
February 25, 2011, this consideration would be equivalent to $44.99 of
Ventas stock for each NHP share, representing a premium to NHP
shareholders of approximately 15% over NHP's closing stock price on that
day. Upon closing of the transaction, Ventas shareholders are expected
to own approximately 65% and NHP shareholders are expected to own
approximately 35% of the combined company. The transaction is expected
to be immediately accretive to Ventas's normalized Funds From Operations
("FFO") and Funds Available for Distribution ("FAD") after the closing,
which is expected to occur in the third quarter of 2011. The all-stock
transaction is intended to be tax-free to shareholders. (All figures for
Ventas and the combined company are pro forma for Ventas's previously
announced transaction to acquire substantially all of the real estate
assets of privately-owned Atria Senior Living Group ("Atria"), which is
expected to close in April 2011.)
"The combination of Ventas and NHP increases the scale and
diversification of the combined company, the strength and flexibility of
the company's balance sheet and the quality and geography of the
assets," Ventas Chairman and Chief Executive Officer Debra A. Cafaro
said. "With Ventas's successful track record of value-creating
transactions and NHP's longstanding history of regional, asset-level
acquisitions, taken together with one of the strongest balance sheets in
the REIT industry, the combined company will have a unique opportunity
for continued external growth. We are excited to move forward with the
NHP team. This combination unites two similar cultures that share core
values and a strong track record of delivering superior returns to
shareholders."
"For NHP shareholders, Ventas is the right partner, bringing the right
value at the right time. After 25 wonderful years of growth and success,
we look forward to joining forces with Ventas, which shares our legacy
of financial strength and top-tier returns for shareholders," said
Douglas M. Pasquale, NHP's Chairman, President and Chief Executive
Officer. "Our shareholders, property operators and tenants will all
benefit from our expanded strength, diversification and capabilities.
We're pleased that this all-stock transaction offers NHP shareholders a
premium and also the opportunity to participate in the combined
company's future prospects for dividends and growth. I am personally
committed to ensuring a smooth transition and the completion of the
transaction as expeditiously as possible."
Strategic and Financial Benefits of Transaction
- Enhanced Scale and Competitiveness. The transaction will create
the largest healthcare REIT, with a pro forma equity value of
approximately $17 billion, pro forma enterprise value of approximately
$23 billion, and over 100 customer relationships. With its enhanced
scale and low leverage, the combined company will be well positioned
to compete for a broad spectrum of transactions, grow and invest in
existing relationships, mine high return redevelopment opportunities
in existing portfolios, maintain a cost of capital advantage and
leverage the talents of the combined Board and management teams.
- Greater Portfolio Diversification by Geography, Asset Class,
Tenant/Operator and Operating Model. The combined company will
have a high quality portfolio with greater diversification across all
key measures.
-
The combined company will have over 1,300 total assets in 47
states, the District of Columbia and two Canadian provinces.
-
Private pay sources will account for 70% of the combined company's
$1.3 billion in NOI.
-
Seniors housing will account for approximately 55% of the combined
company's NOI, with skilled nursing facilities and MOBs accounting
for approximately 22% and 11%, respectively.
-
High growth seniors housing operating assets will account for 26%
of the combined company's NOI, while no single tenant or operator
will account for more than 19% and the top three tenant/operators
together will represent approximately 46%.
-
The combined company will have strong and extensive relationships
with over 100 regional operators and leading tenants and managers,
including Atria, Brookdale Senior Living Inc. (NYSE:BKD), Kindred
Healthcare, Inc. (NYSE:KND) and Sunrise Senior Living, Inc
(NYSE:SRZ).
-
This transaction solidifies Ventas's position as the largest owner
of seniors housing in the United States with 643 assets.
-
The combined company will benefit from a truly national MOB
footprint that includes Ventas's Lillibridge franchise and NHP's
joint venture with Pacific Medical Buildings and extensive
hospital and health-system relationships. The combined company
will have approximately 14 million square feet of owned and
managed MOBs.
-
The combined company will enjoy the stability of triple-net lease
assets and higher growth apartment-like cash flows from seniors
housing operating assets.
- Accretion and Growth Rate. The transaction is expected to be
immediately accretive to Ventas's FFO and FAD. Moreover, the combined
regional and national acquisition capability, low leverage and
competitive costs of capital, national MOB presence and ability to
expand operating assets should enable Ventas to maintain its current
growth profile.
- Financial Strength and Flexibility. The transaction results in
reduced leverage for Ventas. The combined company will maintain a
strong balance sheet and is expected to have the lowest leverage of
the large healthcare REITs, with a debt to enterprise value ratio
below 30% and net debt to EBITDA ratio approximating 5x at closing.
The stronger balance sheet, larger portfolio and increased earnings
diversification are expected to improve the combined company's
long-term cost of capital and credit profile. Both Ventas and NHP have
a track record of prudent balance sheet management. Ventas believes
that the strength of the combined company should create positive
ratings momentum.
- Continued Strong, Secure, Fast-Growing Dividend. The combined
company's shareholders will benefit from a stable and secure dividend
with above-average growth potential, as well as a conservative pro
forma payout ratio. Ventas, which has increased its dividend 8%
annually, on average, since 2004, expects to continue growing its
dividend for shareholders of the combined company post closing. Ventas
had a conservative FFO payout ratio of 74% in 2010 and is expected to
benefit from NHP's stable cash flow from triple-net lease assets,
which have no related capital expenditures. Each company intends to
continue its current dividend until the close of the transaction.
Organization
Debra A. Cafaro, current Chairman and CEO of Ventas, will continue to
serve as Chairman and CEO of the combined company. Douglas M. Pasquale,
current NHP Chairman, President and CEO, will serve as a senior advisor
to ensure an orderly transition. Following the closing of the
transaction, the Ventas Board of Directors will be expanded to include
three directors from NHP, including Mr. Pasquale, bringing the total to
13 members.
Following the merger, Ventas will maintain its corporate headquarters in
Chicago, Illinois.
Approvals and Timing
Completion of the transaction is subject to the approval of shareholders
of both companies and satisfaction of customary closing conditions. The
transaction is expected to close in the third quarter of 2011.
Advisors
Centerview Partners LLC is acting as financial advisor to Ventas, and
Wachtell, Lipton, Rosen & Katz is acting as legal counsel. J.P. Morgan
Securities LLC is acting as financial advisor to NHP, and Skadden, Arps,
Slate, Meagher & Flom LLP is acting as legal counsel.
Conference Call and Webcast
Ventas and NHP will hold a conference call to discuss this transaction
on Monday, February 28, 2011, at 8:30 a.m. Eastern Time (7:30 a.m.
Central Time). The conference call is being webcast and can be accessed
at Ventas's website at www.ventasreit.com
and at NHP's website at www.nhp-reit.com
or by dialing 866-610-1072 and providing the conference ID "48183257". A
replay of the webcast will be available on Ventas's and NHP's websites
or by calling 800-642-1687, referencing conference ID "48183257", at
approximately 11:30 a.m. Eastern Time today. The webcast will be
archived for 30 days.
An investor presentation discussing the NHP transaction will be
available on Ventas's website at www.ventasreit.com
and on NHP's website at www.nhp-reit.com.
About Ventas, Inc.
Ventas, Inc., an S&P 500 company, is a leading healthcare real estate
investment trust. After giving effect to the Atria transaction, its
diverse portfolio will include more than 700 assets in 44 states
(including the District of Columbia) and two Canadian provinces
consisting of seniors housing communities, skilled nursing facilities,
hospitals, medical office buildings and other properties. Through its
Lillibridge subsidiary, Ventas provides management, leasing, marketing,
facility development and advisory services to highly rated hospitals and
health systems throughout the United States. More information about
Ventas and Lillibridge can be found at www.ventasreit.com
and www.lillibridge.com.
About Nationwide Health Properties, Inc.
Nationwide Health Properties, Inc. is a real estate investment trust
that invests primarily in healthcare real estate in the United States.
As of December 31, 2010, the Company's portfolio of properties,
including mortgage loans and properties owned by unconsolidated joint
ventures, totaled 667 properties among the following segments: 298
senior housing facilities, 212 skilled nursing facilities, 134 medical
office buildings, 12 continuing care retirement communities, 7 specialty
hospitals, 2 assets in development and 2 assets held for sale. For more
information on Nationwide Health Properties, Inc., visit its website at www.nhp-reit.com.
This press release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. All
statements regarding Ventas's, NHP's or their respective tenants',
operators', managers' or borrowers' expected future financial position,
results of operations, cash flows, funds from operations, dividends and
dividend plans, financing plans, business strategy, budgets, projected
costs, operating metrics, capital expenditures, competitive positions,
acquisitions, investment opportunities, merger integration, growth
opportunities, dispositions, expected lease income, continued
qualification as a real estate investment trust ("REIT"), plans and
objectives of management for future operations and statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will" and other similar
expressions are forward-looking statements. Such forward-looking
statements are inherently uncertain, and security holders must recognize
that actual results may differ from the companies' expectations. Neither
Ventas nor NHP undertakes a duty to update such forward-looking
statements, which speak only as of the date on which they are made.
Ventas's and NHP's actual future results and trends may differ
materially depending on a variety of factors discussed in their filings
with the Securities and Exchange Commission (the "SEC").These
factors include without limitation: (a) the ability and willingness of
each company's tenants, operators, borrowers, managers and other third
parties to meet and/or perform their obligations under their respective
contractual arrangements with the company, including, in some cases,
their obligations to indemnify, defend and hold harmless the company
from and against various claims, litigation and liabilities; (b) the
ability of each company's tenants, operators, borrowers and managers to
maintain the financial strength and liquidity necessary to satisfy their
respective obligations and liabilities to third parties, including
without limitation obligations under their existing credit facilities
and other indebtedness; (c) each company's success in implementing its
business strategy and its ability to identify, underwrite, finance,
consummate and integrate diversifying acquisitions or investments,
including those in different asset types and outside the United States;
(d) the nature and extent of future competition; (e) the extent of
future or pending healthcare reform and regulation, including cost
containment measures and changes in reimbursement policies, procedures
and rates; (f) increases in each company's cost of borrowing as a result
of changes in interest rates and other factors; (g) the ability of each
company's operators and managers, as applicable, to deliver high quality
services, to attract and retain qualified personnel and to attract
residents and patients; (h) changes in general economic conditions
and/or economic conditions in the markets in which each company may,
from time to time, compete, and the effect of those changes on thecompany's
revenues and its ability to access the capital markets or other sources
of funds; (i) each company's ability to pay down, refinance, restructure
and/or extend its indebtedness as it becomes due; (j) each company's
ability and willingness to maintain its qualification as a REIT due to
economic, market, legal, tax or other considerations; (k) final
determination of each company's taxable net income for the year ended
December 31, 2010 and for the year ending December 31, 2011; (l) the
ability and willingness of each company's tenants to renew their leases
with the company upon expiration of the leases and each company's
ability to reposition its properties on the same or better terms in the
event such leases expire and are not renewed by the tenants or in the
event the company exercises its right to replace an existing tenant upon
default; (m) risks associated with Ventas's senior living operating
portfolio, such as factors causing volatility in its operating income
and earnings generated by its properties, including without limitation
national and regional economic conditions, costs of materials, energy,
labor and services, employee benefit costs, insurance costs and
professional and general liability claims, and the timely delivery of
accurate property-level financial results for those properties; (n) the
movement of U.S. and Canadian exchange rates; (o) year-over-year changes
in the Consumer Price Index and the effect of those changes on the rent
escalators and each company's earnings; (p) each company's ability and
the ability of its tenants, operators, borrowers and managers to obtain
and maintain adequate liability and other insurance from reputable and
financially stable providers; (q) the impact of increased operating
costs and uninsured professional liability claims on the liquidity,
financial condition and results of operations of each company's tenants,
operators, borrowers and managers, and the ability of those tenants,
operators, borrowers and managers to accurately estimate the magnitude
of those claims; (r) risks associated with each company's MOB portfolio
and operations, including its ability to successfully design, develop
and manage MOBs, to accurately estimate its costs in fixed
fee-for-service projects and to retain key personnel; (t) the ability of
the hospitals on or near whose campuses each company's MOBs are located
and their affiliated health systems to remain competitive and
financially viable and to attract physicians and physician groups; (u)
each company's ability to maintain or expand its relationships with its
existing and future hospital and health system clients; (v) risks
associated with each company's investments in joint ventures, including
its lack of sole decision-making authority and its reliance on its joint
venture partners' financial condition; (w) the impact of market or
issuer events on the liquidity or value of each company's investments in
marketable securities; and (x) the impact of any financial, accounting,
legal or regulatory issues or litigation that may affect either company
or its major tenants, operators or managers.Many of these
factors are beyond the control of the companies and their management.
Additional Information about the Proposed Transaction and Where to
Find It
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any securities or a solicitation of any
vote or approval. In connection with the proposed transaction, Ventas
and NHP expect to prepare and file with the SEC a registration statement
on Form S-4 containing a joint proxy statement/prospectus and other
documents with respect to Ventas's proposed acquisition of NHP.
INVESTORS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS
(INCLUDING ALL AMENDMENTS AND SUPPLEMENTS THERETO) AND OTHER RELEVANT
DOCUMENTS FILED WITH THE SEC IF AND WHEN THEY BECOME AVAILABLE BECAUSE
THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.
Investors may obtain free copies of the registration statement, the
joint proxy statement/prospectus and other relevant documents filed by
Ventas and NHP with the SEC (if and when they become available) through
the website maintained by the SEC at www.sec.gov.
Copies of the documents filed by Ventas with the SEC are also available
free of charge on Ventas's website at www.ventasreit.com,
and copies of the documents filed by NHP with the SEC are available free
of charge on NHP's website at www.nhp-reit.com.
Ventas, NHP and their respective directors and executive officers may be
deemed to be participants in the solicitation of proxies from Ventas's
and NHP's shareholders in respect of the proposed transaction.
Information regarding Ventas's directors and executive officers can be
found in Ventas's definitive proxy statement filed with the SEC on March
19, 2010. Information regarding NHP's directors and executive officers
can be found in NHP's definitive proxy statement filed with the SEC on
March 25, 2010. Additional information regarding the interests of such
potential participants will be included in the joint proxy
statement/prospectus and other relevant documents filed with the SEC in
connection with the proposed transaction if and when they become
available. These documents are available free of charge on the SEC's
website and from Ventas or NHP, as applicable, using the sources
indicated above.

SOURCE: Ventas, Inc.
for Ventas:
David J. Smith, (877) 4-VENTAS
or
for NHP:
Abdo H. Khoury, 949-718-4400